Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 537

1.

Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.

Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, La Barba G, Zanello M, Grazi GL, Pinna AD.

Liver Transpl. 2006 Jun;12(6):966-71.

2.

Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease.

Cucchetti A, Ercolani G, Cescon M, Ravaioli M, Zanello M, Del Gaudio M, Lauro A, Vivarelli M, Grazi GL, Pinna AD.

J Am Coll Surg. 2006 Nov;203(5):670-6. Epub 2006 Aug 17.

PMID:
17084328
3.

Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.

Teh SH, Sheppard BC, Schwartz J, Orloff SL.

Am J Surg. 2008 May;195(5):697-701. doi: 10.1016/j.amjsurg.2007.05.054.

PMID:
18367132
4.

Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.

Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU.

Liver Transpl. 2009 May;15(5):496-503. doi: 10.1002/lt.21606.

5.

The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.

Murillas J, Rimola A, Laguno M, de Lazzari E, Rascón J, Agüero F, Blanco JL, Moitinho E, Moreno A, Miró JM; ESLD-HIV Working Group Investigators.

Liver Transpl. 2009 Sep;15(9):1133-41. doi: 10.1002/lt.21735.

6.
8.
9.

Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.

Lv XH, Liu HB, Wang Y, Wang BY, Song M, Sun MJ.

J Gastroenterol Hepatol. 2009 Sep;24(9):1547-53. doi: 10.1111/j.1440-1746.2009.05913.x. Epub 2009 Aug 3.

PMID:
19686416
10.

Is portal hypertension a contraindication to hepatic resection?

Cucchetti A, Ercolani G, Vivarelli M, Cescon M, Ravaioli M, Ramacciato G, Grazi GL, Pinna AD.

Ann Surg. 2009 Dec;250(6):922-8. doi: 10.1097/SLA.0b013e3181b977a5.

PMID:
19855258
11.

Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables.

Cescon M, Cucchetti A, Grazi GL, Ferrero A, Viganò L, Ercolani G, Zanello M, Ravaioli M, Capussotti L, Pinna AD.

Arch Surg. 2009 Jan;144(1):57-63; discussion 63. doi: 10.1001/archsurg.2008.522.

PMID:
19153326
12.

Selecting a short-term prognostic model for hepatocellular carcinoma: comparison between the model for end-stage liver disease (MELD), MELD-sodium, and five cancer staging systems.

Huo TI, Hsia CY, Huang YH, Lin HC, Lee PC, Lui WY, Chiang JH, Chiou YY, Loong CC, Lee SD.

J Clin Gastroenterol. 2009 Sep;43(8):773-81. doi: 10.1097/MCG.0b013e31818dd962.

PMID:
19262404
13.
14.

Management of cirrhotic patients with blunt abdominal trauma: analysis of risk factor of postoperative death with the Model for End-Stage Liver Disease score.

Lin BC, Fang JF, Wong YC, Hwang TL, Hsu YP.

Injury. 2012 Sep;43(9):1457-61. doi: 10.1016/j.injury.2011.03.057. Epub 2011 Apr 20.

PMID:
21511254
15.

The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.

Huo TI, Lin HC, Hsia CY, Huang YH, Wu JC, Chiang JH, Chiou YY, Lui WY, Lee PC, Lee SD.

Dig Liver Dis. 2008 Nov;40(11):882-9. doi: 10.1016/j.dld.2008.01.015. Epub 2008 Mar 12.

PMID:
18339595
16.

Limitation of the model for end-stage liver disease for outcome prediction in patients with cirrhosis-related complications.

Huo TI, Lin HC, Wu JC, Hou MC, Lee FY, Lee PC, Chang FY, Lee SD.

Clin Transplant. 2006 Mar-Apr;20(2):188-94.

PMID:
16640525
17.

Model for end-stage liver disease (MELD) score as a useful prognostic marker in cirrhotic patients with infection.

Khan R, Abid S, Jafri W, Awan S, Hamid S, Shah H, Pervez S.

J Coll Physicians Surg Pak. 2009 Nov;19(11):694-8. doi: 11.2009/JCPSP.694698.

PMID:
19889264
19.

Occurrence of cirrhosis-related complications is a time-dependent prognostic predictor independent of baseline model for end-stage liver disease score.

Huo TI, Lin HC, Lee FY, Hou MC, Lee PC, Wu JC, Chang FY, Lee SD.

Liver Int. 2006 Feb;26(1):55-61.

PMID:
16420510
20.

The impact of the model for end-stage liver disease (MELD) on liver transplantation in one center in Brazil.

Freitas AC, Itikawa WM, Kurogi AS, Stadnik LG, Parolin MB, Coelho JC.

Arq Gastroenterol. 2010 Jul-Sep;47(3):233-7.

Supplemental Content

Support Center